Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Phase Ⅱ, randomized, double-blind, comparator-controlled study to evaluate the efficacy, safety and pharmacokinetics of single injection adductor canal block with HR18034 for postoperative pain management compared with ropivacaine.
Epistemonikos ID: ac68f1fdcf9fc05ec75ff9033b707c5f2fbca7ed
First added on: May 13, 2024